Form 8-K - Current report:
SEC Accession No. 0001193125-23-068406
Filing Date
2023-03-13
Accepted
2023-03-13 06:11:04
Documents
12
Period of Report
2023-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d409752d8k.htm   iXBRL 8-K 23487
  Complete submission text file 0001193125-23-068406.txt   144549

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20230310.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20230310_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20230310_pre.xml EX-101.PRE 11272
6 EXTRACTED XBRL INSTANCE DOCUMENT d409752d8k_htm.xml XML 3407
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 23725598
SIC: 2834 Pharmaceutical Preparations